-
Bioinformatics-Derived Prognostic Biomarkers in Colorectal C
2026-04-22
Huang et al. (2025) integrated large-scale bioinformatics mining and experimental validation to identify a five-gene prognostic signature in colorectal cancer, with TIMP1 emerging as a strong candidate biomarker and therapeutic target. Their work demonstrates a comprehensive pipeline for translating gene expression data into clinically actionable prognostic models.
-
JNK-IN-7 in Apoptosis Mechanisms: Advanced Applications & In
2026-04-22
Explore the science and unique applications of JNK-IN-7, a selective JNK inhibitor, in decoding apoptosis and innate immune signaling. This article offers new depth by integrating recent mechanistic insights and refined assay strategies.
-
Doxorubicin Hydrochloride: Mechanistic Precision in Cancer a
2026-04-21
Explore the dual-role of Doxorubicin hydrochloride in both cancer chemotherapy research and cardiotoxicity modeling. This in-depth article highlights novel mechanistic insights and practical protocols, offering a unique, evidence-driven resource for advanced laboratory applications.
-
Rapamycin (Sirolimus): Autophagy, mTOR, and Next-Gen Tumor M
2026-04-21
Explore how Rapamycin (Sirolimus) unlocks new frontiers in autophagy research and mTOR pathway modulation. This in-depth analysis reveals unique insights into tumor biology, practical assay design, and translational models—grounded in recent breakthroughs and best-in-class reagent data.
-
Dual-Action Kinase Inhibitors Accelerate p38α MAPK Dephospho
2026-04-20
This study uncovers a new mechanism by which certain kinase inhibitors not only block p38α MAPK activity but also stimulate its dephosphorylation by phosphatases. These findings provide structural and mechanistic insight into kinase regulation and have direct relevance for the design of next-generation anti-inflammatory inhibitors.
-
Magnetic Chitosan-Exosome Hydrogel Enhances Bladder Repair i
2026-04-20
This study introduces a magnetic chitosan nanoparticle-exosome hydrogel that improves bladder function in diabetic bladder dysfunction (DBD) by activating the FAK-p38 MAPK-GATA4 axis in adipose-derived mesenchymal stromal cells (ADSCs). The hydrogel demonstrates enhanced targeting, retention, and therapeutic efficacy through sustained delivery of exosomes, providing a promising strategy for regenerative urology.
-
Y-27632 dihydrochloride: Optimized ROCK Inhibition in Cell A
2026-04-19
Y-27632 dihydrochloride delivers highly selective, reproducible ROCK1/2 inhibition, advancing workflows in stem cell viability, cytoskeletal modulation, and tumor invasion assays. This article decodes practical strategies, troubleshooting, and cross-validated insights to empower precise Rho/ROCK pathway control for both foundational and translational research.
-
Fucoidan Downregulates Caveolin-1 in MCF-7 Breast Cancer Cel
2026-04-18
This study reveals that fucoidan, a sulfated α-L-fucan from brown algae, selectively reduces caveolin-1 expression and inhibits proliferation, colony formation, and migration in MCF-7 breast cancer cells. These findings highlight a novel mechanism for fucoidan's antitumor action and suggest its potential as a targeted, less toxic adjunct in breast cancer therapy.
-
2'3'-cGAMP (Sodium Salt): Precision Control of cGAS-STING Im
2026-04-17
Explore how 2'3'-cGAMP (sodium salt) enables rigorous interrogation of the cGAS-STING signaling pathway, uniquely informing assay design and therapeutic discovery. Delve into the latest mechanistic and translational insights, including direct reference to recent breakthroughs in modulating STING-driven inflammation.
-
ABT-199 (GDC-0199): Selective Bcl-2 Inhibitor for Apoptosis
2026-04-16
ABT-199 (Venetoclax) is designed for targeted inhibition of the Bcl-2 protein, enabling highly selective induction of apoptosis in hematologic malignancy models. It is most applicable to workflows focused on non-Hodgkin lymphoma and acute myelogenous leukemia research, but its use is limited to scientific research protocols with established Bcl-2 dependency. Not for diagnostic or therapeutic purposes.
-
Redefining mRNA Reporter Assays: Deep Dive into EZ Cap™ EGFP
2026-04-15
Explore how EZ Cap EGFP mRNA 5-moUTP enables advanced, high-fidelity gene expression studies. This article offers a unique, in-depth analysis of translation efficiency and immunogenicity in mRNA assays, connecting recent scientific breakthroughs to practical lab innovation.
-
Ciprofloxacin Modulates Ferroptosis via Mitochondrial Zinc A
2026-04-14
This study uncovers a novel mechanism by which ciprofloxacin enhances RSL3-induced ferroptosis in cancer cells through mitochondrial Zn²⁺ accumulation mediated by the STING1–CAV2 pathway. The findings reveal the context-dependent dual role of ciprofloxacin in ferroptosis regulation, with implications for targeted cancer therapy.
-
Cyclosporin A: Applied Protocols for Immunosuppression Resea
2026-04-13
Cyclosporin A stands as a benchmark for dissecting T-cell activation and mitochondrial regulation in translational research. This article bridges advanced protocols, troubleshooting, and the latest comparative findings—empowering researchers to maximize assay fidelity and reproducibility.
-
Structural Basis of HCAR3 Agonist Selectivity: Insights from
2026-04-12
This study presents cryo-EM structures of HCAR3 in complex with selective agonists, including Acifran, elucidating the molecular determinants of ligand recognition and selectivity. These findings provide a foundation for developing HCAR3-targeted agents that may avoid the adverse effects associated with HCAR2, advancing lipid metabolism research.
-
Protein A/G Magnetic Beads: Precision in Immunoprecipitation
2026-04-12
Protein A/G Magnetic Beads enable robust antibody purification and highly specific protein-protein interaction analysis, accelerating discovery in stem cell and cancer biology. Their recombinant dual-domain design minimizes background and enhances reproducibility, empowering advanced immunoprecipitation and chromatin studies.
456 records 21/31 page Previous Next First page 上5页 2122232425 下5页 Last page